Study of host–pathogen interactions to identify sustainable vaccine strategies to Marek’s disease

• Published in: Veterinary immunology and immunopathology Vol. 100; no. 3; pp. 165 - 177
• Main Authors: Baaten, B.J.G, Butter, C, Davison, T.F
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2004
• Subjects: Animals; Antibody Formation - immunology; Chicken; Chickens; Cytokines - immunology; Genetic Predisposition to Disease; Herpesvirus; Herpesvirus 2, Gallid - immunology; Immunity; Immunity, Cellular - immunology; Marek Disease - immunology; Marek Disease - pathology; Marek Disease - prevention & control; Marek Disease Vaccines - immunology; Marek Disease Vaccines - therapeutic use; Marek's disease herpesvirus; Marek’s disease; Vaccination - veterinary; Vaccine; Chicken; Vaccine; Marek’s disease; Immunity; Herpesvirus
• ISSN: 0165-2427; 1873-2534
• DOI: 10.1016/j.vetimm.2004.04.009

Marek’s disease virus is a highly cell-associated, lymphotropic α-herpesvirus that causes paralysis and neoplastic disease in chickens. The disease has been contained by vaccination with attenuated viruses and provides the first evidence for a malignant cancer being controlled by an antiviral vaccine. Marek’s disease pathogenesis is complex, involving cytolytic and latent infection of lymphoid cells and oncogenic transformation of CD4 + T cells in susceptible chickens. Innate and adaptive immune responses develop in response to infection, but infection of lymphocytes results in immunosuppressive effects. The remarkable ability of MDV to escape immune responses by interacting with, and down-regulating, some key aspects of the immune system will be discussed in the context of genetic resistance. Resistance conferred by vaccination and the implications of targeting replicative stages of the virus will also be examined.